ask="3.77"
ask_size="500"
average_daily_volume="44360"
bid="N/A"
bid_size="N/A"
book_value="-0.93"
change="-0.05"
change_from_200_day_moving_average="-0.92"
change_from_50_day_moving_average="-0.54"
change_from_52_week_high="-2.81"
change_From_52_week_low="0.88"
change_in_percent="-1.83%"
close="2.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-1.26"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10398000"
high="2.68"
high_52_weeks="5.49"
last_trade_date="3/9/2017"
last_trade_price="2.68"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.45"
low_52_weeks="1.80"
market_capitalization="63.33M"
moving_average_200_day="3.60"
moving_average_50_day="3.22"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="9.67"
open="2.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.60%"
percent_change_from_50_day_moving_average="-16.70%"
percent_change_from_52_week_high="-51.18%"
percent_change_from_52_week_low="+48.57%"
previous_close="2.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="28.20"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="0.89"
stock_exchange="NGM"
symbol="ONS"
volume="49900"
weeks_range_52="1.80 - 5.49"
